Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI / NKI-AVL)

Research facility

Location: Amsterdam, Netherlands (NL)

ISNI: 0000000106741393

ROR: https://ror.org/03xqtf034

Show on Map:

Publications

(191)

Research Grants

(1)

Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy (2025) Rinderknecht E, Claps F, Bostrom PJ, Shariat SF, Neuzillet Y, Zlotta AR, Trombetta C, et al. Journal article Letter: Updates to Microhematuria: AUA/SUFU Guideline (2025) (2025) Shariat SF, Van Rhijn BW, Bolenz C, Witjes JA, Burger M, Schmitz-Dräger BJ Journal article Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer (2025) Hoppe R, Winter S, Lo WY, Michailidou K, Bolla MK, Keeman R, Wang Q, et al. Journal article Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma (2025) Dummer R, Sandhu S, Miller WH, Butler MO, Taylor MH, Heinzerling L, Blank CU, et al. Journal article Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma. (2025) Wolchok JD, Chiarion-Sileni V, Rutkowski P, Cowey CL, Schadendorf D, Wagstaff J, Queirolo P, et al. Journal article ESR Essentials: common performance metrics in AI—practice recommendations by the European Society of Medical Imaging Informatics (2025) Klontzas ME, Groot Lipman KB, Akinci D’ Antonoli T, Andreychenko A, Cuocolo R, Dietzel M, Gitto S, et al. Journal article, Review article A Systematic Review and Meta-analysis on Perioperative Stenting/Dwell Time and Postoperative Outcomes in Patients Undergoing Radical Cystectomy and Urinary Diversion for Bladder Cancer (2025) Kailavasan M, Martini A, Bruins M, Carrion A, Cathomas R, Compérat E, Efstathiou JA, et al. Journal article, Review article Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial (2025) Bergmann L, Albiges L, Ahrens M, Gross-Goupil M, Boleti E, Gravis G, Fléchon A, et al. Journal article Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study (2025) Downes MR, Lajkosz K, Algaba F, Allory Y, Amin MB, Cheng L, Desai S, et al. Journal article European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines (2025) van der Heijden AG, Bruins HM, Carrion A, Cathomas R, Compérat E, Dimitropoulos K, Efstathiou JA, et al. Journal article

‹ 1 2 3 ... 20 ›